| Description | SARS-CoV-IN-2 is an effective SARS-CoV replication inhibitor |
| In vitro | In vitro growth of Plasmodium falciparum inhibited by SARS-CoV-IN-2 far better than Chloroquine (CQ) . |
| Target activity | SARS-CoV (Vero cells):1.9 μM (EC50) , P. falciparum (W2):30 nM , P. falciparum (W2):99.9 nM , P. falciparum (3D7):21.5 nM , P. falciparum (3D7):IC90: 51.0 nM |
| molecular weight | 463.78 |
| Molecular formula | C24H26ClFeN3O |
| CAS | 888958-26-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Biot C, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9. |